Kuur Therapeutics

Kuur Therapeutics is committed to transforming the lives of cancer patients and leading the development of off-the-shelf engineered CAR-NKT cell therapies. Their approach combines the highly specialized natural biological properties of a specific subset of T cells, known as Natural Killer T cells (NKT cells), with innovative Chimeric Antigen Receptor (CAR) construct engineering. Together, this provides a highly compelling and unique platform.